Our free access period ends on the 18th April 2022. To find out about membership to Sustain RE, please contact us.

Nuveen funds sustainable life sciences project

8th February 2024

Nuveen Real Estate will provide a €35 million ($38 million) senior secured loan for the acquisition and construction of One Helix, a cutting-edge life science asset situated in Amsterdam.

One Helix will be developed by a joint venture between Tishman Speyer and Bellco Capital, with the entire 5,155 sq m facility pre-let to Neogene, a biotechnology company specializing in T cell receptor therapies for cancers. Neogene is a subsidiary of AstraZeneca.

The loan is part of Nuveen's pan-European debt strategy, which prioritizes investments in environmentally conscious projects. This marks the strategy's second investment, following a €54 million agreement to finance logistics assets in Berlin for Valor.

One Helix is slated to achieve BREEAM "Outstanding" and will support carbon-negative operations through geothermal heating and cooling systems and rooftop solar panels.

Share this article